Seizure: European Journal of Epilepsy
Volume 19, Issue 5 , Pages 264-268, June 2010

Vagus nerve stimulation: Outcome and predictors of seizure freedom in long-term follow-up

  • Kazem Ghaemi

      Affiliations

    • Department of Neurosurgery, Birjand University of Medical Science, Iran
    • Department of Neurosurgery, Bethel Epilepsy Center, Germany
    • Corresponding Author InformationCorresponding authors at: Klinik Mara, Maraweg 21, 33617 Bielefeld, Germany. Tel.: +49 52177278870; fax: +49 52177278872.
  • ,
  • Alaa Eldin Elsharkawy

      Affiliations

    • Department of Presurgical Evaluation, Bethel Epilepsy Center, Germany
    • Department of Neurosurgery, Bethel Epilepsy Center, Germany
    • Corresponding Author InformationCorresponding authors at: Klinik Mara, Maraweg 21, 33617 Bielefeld, Germany. Tel.: +49 52177278870; fax: +49 52177278872.
  • ,
  • Reinhard Schulz

      Affiliations

    • Department of Presurgical Evaluation, Bethel Epilepsy Center, Germany
  • ,
  • Matthias Hoppe

      Affiliations

    • Department of Presurgical Evaluation, Bethel Epilepsy Center, Germany
  • ,
  • Tilman Polster

      Affiliations

    • Department of Presurgical Evaluation, Bethel Epilepsy Center, Germany
  • ,
  • Heinz Pannek

      Affiliations

    • Department of Neurosurgery, Bethel Epilepsy Center, Germany
  • ,
  • Alois Ebner

      Affiliations

    • Department of Presurgical Evaluation, Bethel Epilepsy Center, Germany
    • Corresponding Author InformationCorresponding authors at: Klinik Mara, Maraweg 21, 33617 Bielefeld, Germany. Tel.: +49 52177278870; fax: +49 52177278872.

Received 3 October 2009; received in revised form 4 February 2010; accepted 5 March 2010. published online 02 April 2010.

Abstract 

Objectives

To present long-term outcome and to identify predictors of seizure freedom after vagus nerve stimulation (VNS).

Methods

All patients who had undergone VNS implantation in the Epilepsy Centre Bethel were retrospectively reviewed. There were 144 patients who had undergone complete presurgical evaluation, including detailed clinical history, magnetic resonance imaging, and long-term video-EEG with ictal and interictal recordings. After implantation, all patients were examined at regular intervals of 4 weeks for 6–9 months. During this period the antiepileptic medication remained constant. All patients included in this study were followed up for a minimum of 2 years.

Result

Ten patients remained seizure-free for more than 1 year after VNS implantation (6.9%). Seizures improved in 89 patients (61.8%) but no changes were observed in 45 patients (31.3%). The following factors were significant in the univariate analysis: age at implantation, multifocal interictal epileptiform discharges, unilateral interictal epileptiform discharge, cortical dysgenesis, and psychomotor seizure. Stepwise multivariate analysis showed that unilateral interictal epileptiform discharges (IEDs), P=0.014, HR=0.112 (95% CIs, 0.019–0.642), cortical dysgenesis P=0.007, HR=0.065 (95% CIs, 0.009–0.481) and younger age at implantation P=0.026, HR=7.533 (95% CIs 1.28–44.50) were independent predictors of seizure freedom in the long-term follow-up.

Conclusion

VNS implantation may render patients with some forms of cortical dysgenesis (parietooccipital polymicrogyria, macrogyria) seizure-free. Patients with unilateral IEDs and earlier implantation achieved the most benefit from VNS.

Keywords: VNS, Long-term outcome, Epilepsy

 

PII: S1059-1311(10)00056-7

doi:10.1016/j.seizure.2010.03.002

Seizure: European Journal of Epilepsy
Volume 19, Issue 5 , Pages 264-268, June 2010